Navigation Links
Pharma Base S.A. Launches Osamine(TM) Pharmaceutical Grade Glucosamine in North America
Date:4/24/2008

PFAFFIKON, Switzerland, April 24 /PRNewswire/ -- Pharma Base S.A. announces the launch of Osamine(TM) Pharmaceutical Grade Glucosamine for the North American Dietary Supplement, Personal Care and Food industries. Available as both Glucosamine Hydrochloride and Glucosamine Sulphate, Osamine(TM) brings forward high quality pharmaceutical grade glucosamine to the worldwide marketplace.

"With a greater focus on ingredient quality and a strong demand for raw material sources outside of China, the North American marketplace is ready for a superior quality ingredient like Osamine(TM). Having been sold over the last decade in Europe, Japan and India, we are thrilled to introduce this ingredient to the Americas." says Russ Anderson, President of Pharma Base North America.

About Pharma Base

Pharma Base S.A., founded in 1996, is a privately-held company dedicated to improving the lives of people through the research and discovery of naturally occurring compounds. Our commitment is to manufacture and distribute clinically proven, safe and effective high-quality products manufactured in cGMP facilities, thereby helping to elevate the standards and quality of dietary supplements. The company is headquartered in Switzerland with additional locations in India and North America.
For more information:

http://www.osamine.com

http://www.pharmabase.com


'/>"/>
SOURCE Pharma Base S.A.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Prime Hires Rachelle Wan as Vice President of Pharmaceutical Trade Relations
2. The Quigley Corporation Reports First Quarter 2008 Results - Increases Investment in Pharmaceutical R&D Future
3. Pharmacyclics Reports Third Quarter 2008 Financial Results
4. Complimentary Excerpt Available from Best Practices: Pharmaceutical Competitive Intelligence Excellence - Optimizing Data Collection within Approved Guidelines
5. Jazz Pharmaceuticals to Present at Morgan Stanley Conference
6. Aida Pharmaceuticals, Inc. Announces Availability of Downloadable Corporate Synopsis on its Website
7. Medco, UnitedHealth Group Announce Pharmacy Services Agreement
8. Simcere Pharmaceutical Group Acquires 70% Stake in Wuhu Zhong Ren Pharmaceutical Co. Ltd.
9. ISTA Pharmaceuticals Announces Conference Call and Webcast of First Quarter 2008 Financial Results
10. Law Offices of Howard G. Smith Announces 21 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Vertex Pharmaceuticals Inc.
11. Amylin Pharmaceuticals Reports First Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... ... March 22, 2017 , ... HealthiPASS, Inc., announces ... creating a positive patient experience. , HealthiPASS has further enhanced its predictive ... by helping them understand their financial responsibility. “Our latest release focuses on ...
(Date:3/22/2017)... CA (PRWEB) , ... March 22, 2017 , ... Nearly ... should not undergo PSA (prostate-specific antigen) screening, the cancer screening continues to stir controversy. ... 2008 because it found that the risks outweighed the benefits. Now, news from ...
(Date:3/22/2017)... ... , ... The National Association for Business Resources (NABR) has recently ... in Wellness® companies for 2017. , American Specialty Health (ASH) was honored ... for its employees. ASH is one of only nine other San Diego companies being ...
(Date:3/22/2017)... ... March 22, 2017 , ... Winter ... reduces pigmentation to enhance surgical and nonsurgical procedures—Lytera 2.0 by SkinMedica. Lytera 2.0 ... the face, neck and décolletage in as little as 4 weeks. Skin pigmentation ...
(Date:3/20/2017)... ... ... The topic of healthcare in America has become one of the most ... is that they are still left without the health insurance coverage they need in ... that an unfortunate side-effect of this scenario is that hospital emergency rooms and urgent ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... , March 22, 2017 ... the growing legal cannabis industry is strongly contributing to ... provides comprehensive analysis and reporting for the cannabis industry, ... create more than a quarter million jobs for American ... $7.2 billion in 2016, and is projected to grow ...
(Date:3/22/2017)... March 22, 2017  As the world,s leading non-profit ... Society (LLS) has played a role in most therapies ... which are even helping patients with other cancers and ... significant investment in cutting-edge research – more than $1 ... grow with the record-breaking sum of $4.1 million raised ...
(Date:3/22/2017)... SANTA CLARA, Calif. , March 22, 2017 ... diagnostic cardiology  solutions segment, Frost & Sullivan recognizes ... Sullivan Company of the Year Award. GE Healthcare,s ... offer end-to-end cardiac solutions has allowed it to ... competitive cardiac monitoring products space. In addition to ...
Breaking Medicine Technology: